Literature DB >> 18852469

Network model of survival signaling in large granular lymphocyte leukemia.

Ranran Zhang1, Mithun Vinod Shah, Jun Yang, Susan B Nyland, Xin Liu, Jong K Yun, Réka Albert, Thomas P Loughran.   

Abstract

T cell large granular lymphocyte (T-LGL) leukemia features a clonal expansion of antigen-primed, competent, cytotoxic T lymphocytes (CTL). To systematically understand signaling components that determine the survival of CTL in T-LGL leukemia, we constructed a T-LGL survival signaling network by integrating the signaling pathways involved in normal CTL activation and the known deregulations of survival signaling in leukemic T-LGL. This network was subsequently translated into a predictive, discrete, dynamic model. Our model suggests that the persistence of IL-15 and PDGF is sufficient to reproduce all known deregulations in leukemic T-LGL. This finding leads to the following predictions: (i) Inhibiting PDGF signaling induces apoptosis in leukemic T-LGL. (ii) Sphingosine kinase 1 and NFkappaB are essential for the long-term survival of CTL in T-LGL leukemia. (iii) NFkappaB functions downstream of PI3K and prevents apoptosis through maintaining the expression of myeloid cell leukemia sequence 1. (iv) T box expressed in T cells (T-bet) should be constitutively activated concurrently with NFkappaB activation to reproduce the leukemic T-LGL phenotype. We validated these predictions experimentally. Our study provides a model describing the signaling network involved in maintaining the long-term survival of competent CTL in humans. The model will be useful in identifying potential therapeutic targets for T-LGL leukemia and generating long-term competent CTL necessary for tumor and cancer vaccine development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18852469      PMCID: PMC2571012          DOI: 10.1073/pnas.0806447105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  Circuitry of nuclear factor kappaB signaling.

Authors:  Alexander Hoffmann; David Baltimore
Journal:  Immunol Rev       Date:  2006-04       Impact factor: 12.988

2.  Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin.

Authors:  Andrew M Intlekofer; Naofumi Takemoto; E John Wherry; Sarah A Longworth; John T Northrup; Vikram R Palanivel; Alan C Mullen; Christopher R Gasink; Susan M Kaech; Joseph D Miller; Laurent Gapin; Kenneth Ryan; Andreas P Russ; Tullia Lindsten; Jordan S Orange; Ananda W Goldrath; Rafi Ahmed; Steven L Reiner
Journal:  Nat Immunol       Date:  2005-11-06       Impact factor: 25.606

3.  Pathologic clonal cytotoxic T-cell responses: nonrandom nature of the T-cell-receptor restriction in large granular lymphocyte leukemia.

Authors:  Marcin W Wlodarski; Christine O'Keefe; Evan C Howe; Antonio M Risitano; Alexander Rodriguez; Ilka Warshawsky; Thomas P Loughran; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2005-05-24       Impact factor: 22.113

4.  Robustness and fragility of Boolean models for genetic regulatory networks.

Authors:  Madalena Chaves; Réka Albert; Eduardo D Sontag
Journal:  J Theor Biol       Date:  2005-03-19       Impact factor: 2.691

5.  T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia.

Authors:  Elena E Solomou; Keyvan Keyvanfar; Neal S Young
Journal:  Blood       Date:  2006-01-24       Impact factor: 22.113

Review 6.  Mechanism of action and in vivo role of platelet-derived growth factor.

Authors:  C H Heldin; B Westermark
Journal:  Physiol Rev       Date:  1999-10       Impact factor: 37.312

7.  ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL).

Authors:  Pearlie K Epling-Burnette; Fanqi Bai; Sheng Wei; Pratima Chaurasia; Jeffrey S Painter; Nancy Olashaw; Andrew Hamilton; Said Sebti; Julie Y Djeu; Thomas P Loughran
Journal:  Oncogene       Date:  2004-12-09       Impact factor: 9.867

8.  Constitutive production of proinflammatory cytokines RANTES, MIP-1beta and IL-18 characterizes LGL leukemia.

Authors:  Ravi Kothapalli; Susan B Nyland; Irina Kusmartseva; Ratna D Bailey; Tylee M McKeown; Thomas P Loughran
Journal:  Int J Oncol       Date:  2005-02       Impact factor: 5.650

9.  Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia.

Authors:  T Lamy; J H Liu; T H Landowski; W S Dalton; T P Loughran
Journal:  Blood       Date:  1998-12-15       Impact factor: 22.113

Review 10.  Large granular lymphocyte leukemia.

Authors:  Lubomir Sokol; Thomas P Loughran
Journal:  Oncologist       Date:  2006-03
View more
  133 in total

1.  Unraveling the complex regulatory relationships between metabolism and signal transduction in cancer.

Authors:  Michelle L Wynn; Sofia D Merajver; Santiago Schnell
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

2.  A molecular and functional analysis of large granular lymphocyte expansions in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors.

Authors:  John J Powers; Jason A Dubovsky; P K Epling-Burnette; Lynn Moscinski; Ling Zhang; Satu Mustjoki; Eduardo M Sotomayor; Javier A Pinilla-Ibarz
Journal:  Leuk Lymphoma       Date:  2011-01-27

Review 3.  Dynamical systems approach to endothelial heterogeneity.

Authors:  Erzsébet Ravasz Regan; William C Aird
Journal:  Circ Res       Date:  2012-06-22       Impact factor: 17.367

Review 4.  Intracellular and intercellular signaling networks in cancer initiation, development and precision anti-cancer therapy: RAS acts as contextual signaling hub.

Authors:  Peter Csermely; Tamás Korcsmáros; Ruth Nussinov
Journal:  Semin Cell Dev Biol       Date:  2016-07-06       Impact factor: 7.727

5.  Somatic STAT3 mutations in large granular lymphocytic leukemia.

Authors:  Hanna L M Koskela; Samuli Eldfors; Pekka Ellonen; Arjan J van Adrichem; Heikki Kuusanmäki; Emma I Andersson; Sonja Lagström; Michael J Clemente; Thomas Olson; Sari E Jalkanen; Muntasir Mamun Majumder; Henrikki Almusa; Henrik Edgren; Maija Lepistö; Pirkko Mattila; Kathryn Guinta; Pirjo Koistinen; Taru Kuittinen; Kati Penttinen; Alun Parsons; Jonathan Knowles; Janna Saarela; Krister Wennerberg; Olli Kallioniemi; Kimmo Porkka; Thomas P Loughran; Caroline A Heckman; Jaroslaw P Maciejewski; Satu Mustjoki
Journal:  N Engl J Med       Date:  2012-05-17       Impact factor: 91.245

6.  COMPUTATIONAL METHODS FOR ASYNCHRONOUS BASINS.

Authors:  Ian H Dinwoodie
Journal:  Discrete Continuous Dyn Syst Ser B       Date:  2016-11-01       Impact factor: 1.327

Review 7.  Toward the dynamic interactome: it's about time.

Authors:  Teresa M Przytycka; Mona Singh; Donna K Slonim
Journal:  Brief Bioinform       Date:  2010-01-08       Impact factor: 11.622

8.  Large granular lymphocyte disorders: new etiopathogenetic clues as a rationale for innovative therapeutic approaches.

Authors:  Renato Zambello; Gianpietro Semenzato
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

Review 9.  Advances in the Diagnosis and Treatment of Large Granular Lymphocytic Leukemia.

Authors:  HeeJin Cheon; Karolina H Dziewulska; Katharine B Moosic; Kristine C Olson; Alejandro A Gru; David J Feith; Thomas P Loughran
Journal:  Curr Hematol Malig Rep       Date:  2020-04       Impact factor: 3.952

Review 10.  Never say die: survival signaling in large granular lymphocyte leukemia.

Authors:  Mithun Vinod Shah; Ranran Zhang; Thomas P Loughran
Journal:  Clin Lymphoma Myeloma       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.